314 related articles for article (PubMed ID: 12842348)
21. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
22. Physicochemical and molecular modeling studies of cefixime-L-arginine-cyclodextrin ternary inclusion compounds.
Jadhav P; Petkar B; Pore Y; Kulkarni A; Burade K
Carbohydr Polym; 2013 Nov; 98(2):1317-25. PubMed ID: 24053809
[TBL] [Abstract][Full Text] [Related]
23. Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
Boudad H; Legrand P; Lebas G; Cheron M; Duchêne D; Ponchel G
Int J Pharm; 2001 May; 218(1-2):113-24. PubMed ID: 11337155
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization.
Cirri M; Maestrelli F; Corti G; Furlanetto S; Mura P
J Pharm Biomed Anal; 2006 Sep; 42(1):126-31. PubMed ID: 16406448
[TBL] [Abstract][Full Text] [Related]
25. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers.
Mura P; Faucci MT; Maestrelli F; Furlanetto S; Pinzauti S
J Pharm Biomed Anal; 2002 Aug; 29(6):1015-24. PubMed ID: 12110386
[TBL] [Abstract][Full Text] [Related]
26. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
Cavalli R; Peira E; Caputo O; Gasco MR
Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
[TBL] [Abstract][Full Text] [Related]
27. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
28. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
[TBL] [Abstract][Full Text] [Related]
29. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
Taupitz T; Dressman JB; Buchanan CM; Klein S
Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
[TBL] [Abstract][Full Text] [Related]
30. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.
Gladys G; Claudia G; Marcela L
Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
Vlachou M; Papaïoannou G
J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
[TBL] [Abstract][Full Text] [Related]
32. Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-beta-cyclodextrin inclusion complex.
Filipović-Grcić J; Voinovich D; Moneghini M; Becirevic-Lacan M; Magarotto L; Jalsenjak I
Eur J Pharm Sci; 2000 Feb; 9(4):373-9. PubMed ID: 10664477
[TBL] [Abstract][Full Text] [Related]
33. Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids.
Cirri M; Maestrelli F; Mennini N; Mura P
J Pharm Biomed Anal; 2009 Dec; 50(5):683-9. PubMed ID: 19095391
[TBL] [Abstract][Full Text] [Related]
34. Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex.
Valero M; Pérez-Revuelta BI; Rodríguez LJ
Int J Pharm; 2003 Mar; 253(1-2):97-110. PubMed ID: 12593941
[TBL] [Abstract][Full Text] [Related]
35. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
36. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
Moore E; Bergamo R; Casella R
Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
[TBL] [Abstract][Full Text] [Related]
37. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
38. Formulation and Characterization of a Ternary Inclusion Complex Containing Hydroxypropyl-β-cyclodextrin and Meglumine for Solubility Enhancement of Poorly Water-Soluble ST-246, an Anti-Smallpox Drug.
Li X; Yang M; Li Y; Gong W; Wang Y; Shan L; Shao S; Gao C; Zhong W
Curr Drug Deliv; 2017; 14(8):1130-1143. PubMed ID: 27697036
[TBL] [Abstract][Full Text] [Related]
39. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
40. Effect of hydroxypropyl-beta-cyclodextrin on the solubility of an antibacterial isoxazolyl-naphthoquinone.
Linares MS; de Bertorello MM; Longhi MR
Drug Dev Ind Pharm; 2000 Sep; 26(9):1003-6. PubMed ID: 10914326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
